Analystreport

Karyopharm Therapeutics (NASDAQ:KPTI) was given a new $12.00 price target on by analysts at The Goldman Sachs Group, Inc..

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations